← back to search

Johannes Czernin

University of California, Los Angeles · US
Area of research
Radiology, Nuclear Medicine and Imaging · Pulmonary and Respiratory Medicine
Research interest
Research interests include Medical Imaging Techniques and Applications, Prostate Cancer Treatment and Research, Radiopharmaceutical Chemistry and Applications, and Radiomics and Machine Learning in Medical Imaging.
h-index
23
citations
2,963
works
96
NIH funding
primary concept
email

Recent publications

PSMA-PET/CT Findings in Patients With High-Risk Biochemically Recurrent Prostate Cancer With No Metastatic Disease by Conventional Imaging
JAMA Network Open 2025cited by 53position: middledoi
Low- and High-Volume Disease in Metastatic Hormone-Sensitive Prostate Cancer: From CHAARTED to PSMA PET—An International Multicenter Retrospective Study
Journal of Nuclear Medicine 2025cited by 22position: middledoi
<sup>177</sup> Lu-Prostate-Specific Membrane Antigen Neoadjuvant to Stereotactic Ablative Radiotherapy for Oligorecurrent Prostate Cancer (LUNAR): An Open-Label, Randomized, Controlled, Phase II Study
Journal of Clinical Oncology 2025cited by 13position: middledoi
Randomized Phase 2 Trial of an Extended and Flexible Dosing Schedule of <sup>177</sup>Lu-PSMA Molecular Radiotherapy in Patients with Metastatic Castration-Resistant Prostate Cancer (FLEX-MRT): Study Protocol
Journal of Nuclear Medicine 2025cited by 5position: middledoi
Development of a leucine-rich repeat-containing protein 15-targeted radio-immunotheranostic approach to deplete pro-tumorigenic mechanisms and immunotherapy resistance
Signal Transduction and Targeted Therapy 2025cited by 2position: middledoi
Correlation of FAPI PET Uptake with Immunohistochemistry in Explanted Lungs from Patients with Advanced Interstitial Lung Disease
Journal of Nuclear Medicine 2024cited by 19position: middledoi
Co-targeting of convergent nucleotide biosynthetic pathways for leukemia eradication
The Journal of Experimental Medicine 2014cited by 44position: middledoi
18F-FDOPA and 18F-FLT positron emission tomography parametric response maps predict response in recurrent malignant gliomas treated with bevacizumab
Neuro-Oncology 2012cited by 106position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Jérémie Calais · Dana-Farber Cancer Institute4 papers (2024–2025)Wesley R. Armstrong · University of California System3 papers (2024–2025)Amar U. Kishan · University of Colorado Denver2 papers (2025–2025)Matthew B. Rettig · University of Southern California2 papers (2025–2025)Adrien Holzgreve · LMU Klinikum2 papers (2025–2025)Matthias Benz · University of California, Los Angeles2 papers (2025–2025)Magnus Dahlbom · University of California, Los Angeles2 papers (2024–2025)Tristan Grogan · Norwegian Womens Public Health Association2 papers (2025–2025)Lena M. Unterrainer · LMU Klinikum2 papers (2025–2025)Honest Ndlovu · Steve Biko Hospital1 papers (2025–2025)Phioanh L. Nghiemphu · University of Minnesota1 papers (2012–2012)Giuseppe Carlucci · University of California, Los Angeles1 papers (2024–2024) · 1 papers (2025–2025)Albert Lai · APLA Health1 papers (2012–2012)Catherine Meyer · Molecular Theranostics (United States)1 papers (2025–2025)Wei Chen · BGI Research1 papers (2012–2012)Pan Thin · Molecular Theranostics (United States)1 papers (2025–2025)Nicholas G. Nickols · University of California, Los Angeles1 papers (2025–2025)Wolfgang P. Fendler · Molecular Theranostics (United States)1 papers (2025–2025)Grace Hyun J. Kim · Lucile Packard Children's Hospital1 papers (2024–2024)